logo-loader
viewBiotechnology Innovation Organization

SFA Therapeutics developing its psoriasis therapy to showcase its anti-inflammatory platform

SFA Therapeutics, Inc CEO Dr. Ira Spector sat down with Proactive at the BIO Investor Forum in San Francisco. The Pennsylvania-based company, using microbiome-derived metabolites as drugs, is advancing its oral treatment for psoriasis into Phase 2 clinical studies.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks show little excitement; AgraFlora jumps on UK...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, declined 0.8% to 120.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF rose 0.2% to C$9.67, while the OTCQX Cannabis index edged down 0.2% to 488.6 points. Buds today...

14 hours, 27 minutes ago

2 min read